These final results, along with a prior report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 guidance the strategy of targeting ACKR3 as a singular method to modulate the opioid program, which could open new therapeutic avenues for opioid-related Ailments.Gene expression analysis exposed that ACKR3